TY - JOUR
T1 - Activation of MKK6, an upstream activator of p38, in Alzheimer's disease
AU - Zhu, Xiongwei
AU - Rottkamp, Catherine A.
AU - Hartzler, Anthony
AU - Sun, Zheng
AU - Takeda, Atsushi
AU - Boux, Heather
AU - Shimohama, Shun
AU - Perry, George
AU - Smith, Mark A.
PY - 2001
Y1 - 2001
N2 - Mitogen-activated protein kinase (MAPK) p38 has been implicated in the pathogenesis of Alzheimer's disease, but the upstream cascade leading to p38 activation has not been elucidated in the disease. In the present study, we focused on mitogen-activated protein kinase kinase 6 (MKK6), one of the upstream activators of p38 MAPK. We found that MKK6 was not only increased but also specifically associated with granular structures in the susceptible neurons in the hippocampus and cortex of Alzheimer's disease patients, but was only weakly diffuse in the cytoplasm in neurons in control cases. Immunoblot analysis demonstrated a significant increase of MKK6 level in Alzheimer's disease compared with age-matched controls. In this regard, in hippocampal and cortical regions of individuals with Alzheimer's disease, the activated phospho-MKK6 was localized exclusively in association with pathological alterations including neurofibrillary tangles, senile plaques, neuropil threads and granular structures, overlapping with activated p38 MAPK suggesting both a functional and mechanic link. By immunoblot analysis, phospho-MKK6 is also significantly increased in AD compared with control cases. Together, these findings lend further credence to the notion that the p38 MAPK pathway is dysregulated in Alzheimer's disease and also indicates an active role for this pathway in disease pathogenesis.
AB - Mitogen-activated protein kinase (MAPK) p38 has been implicated in the pathogenesis of Alzheimer's disease, but the upstream cascade leading to p38 activation has not been elucidated in the disease. In the present study, we focused on mitogen-activated protein kinase kinase 6 (MKK6), one of the upstream activators of p38 MAPK. We found that MKK6 was not only increased but also specifically associated with granular structures in the susceptible neurons in the hippocampus and cortex of Alzheimer's disease patients, but was only weakly diffuse in the cytoplasm in neurons in control cases. Immunoblot analysis demonstrated a significant increase of MKK6 level in Alzheimer's disease compared with age-matched controls. In this regard, in hippocampal and cortical regions of individuals with Alzheimer's disease, the activated phospho-MKK6 was localized exclusively in association with pathological alterations including neurofibrillary tangles, senile plaques, neuropil threads and granular structures, overlapping with activated p38 MAPK suggesting both a functional and mechanic link. By immunoblot analysis, phospho-MKK6 is also significantly increased in AD compared with control cases. Together, these findings lend further credence to the notion that the p38 MAPK pathway is dysregulated in Alzheimer's disease and also indicates an active role for this pathway in disease pathogenesis.
KW - Alzheimer's disease
KW - Cell cycle
KW - Mitogen-activated protein kinase kinase 6
KW - Oxidative stress
KW - P38
UR - http://www.scopus.com/inward/record.url?scp=0034781046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034781046&partnerID=8YFLogxK
U2 - 10.1046/j.1471-4159.2001.00597.x
DO - 10.1046/j.1471-4159.2001.00597.x
M3 - Article
C2 - 11677259
AN - SCOPUS:0034781046
SN - 0022-3042
VL - 79
SP - 311
EP - 318
JO - Journal of neurochemistry
JF - Journal of neurochemistry
IS - 2
ER -